Open Access

Simultaneous circulation of genotypes I and III of dengue virus 3 in Colombia

  • Jose A Usme-Ciro1,
  • Jairo A Mendez3,
  • Antonio Tenorio4,
  • Gloria J Rey3,
  • Cristina Domingo4 and
  • Juan C Gallego-Gomez1, 2Email author
Contributed equally
Virology Journal20085:101

DOI: 10.1186/1743-422X-5-101

Received: 02 July 2008

Accepted: 02 September 2008

Published: 02 September 2008

Abstract

Background

Dengue is a major health problem in tropical and subtropical regions. In Colombia, dengue viruses (DENV) cause about 50,000 cases annually, 10% of which involve Dengue Haemorrhagic Fever/Dengue Shock Syndrome. The picture is similar in other surrounding countries in the Americas, with recent outbreaks of severe disease, mostly associated with DENV serotype 3, strains of the Indian genotype, introduced into the Americas in 1994.

Results

The analysis of the 3'end (224 bp) of the envelope gene from 32 DENV-3 strains recently recovered in Colombia confirms the circulation of the Indian genotype, and surprisingly the co-circulation of an Asian-Pacific genotype only recently described in the Americas.

Conclusion

These results have important implications for epidemiology and surveillance of DENV infection in Central and South America. Molecular surveillance of the DENV genotypes infecting humans could be a very valuable tool for controlling/mitigating the impact of the DENV infection.

Background

Dengue viruses (DENV) belong to the genus Flavivirus, transmitted by Aedes mosquitoes and constitutes a major concern in public health, infecting millions of people per year in tropical and subtropical areas throughout the world. DENV causes a wide spectrum of clinical manifestations in humans, ranging from a flu-like illness, known as Dengue Fever (DF), to the more severe Dengue Haemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS).

DENV are enveloped viruses with a positive sense ssRNA of about 11 kb coding a single open reading frame for three structural and seven non-structural proteins [1]. Additionally, DENV comprises four distinct serotypes (DENV-1, DENV-2, DENV-3 and DENV-4) and infection with any of them can produce the most severe manifestations of illness [2].

Although four DENV serotypes can be differentiated by immunofluorescence, it does not provide information about epidemiologic origin and phylogenetic relationship between strains from different geographic regions. In fact, studies of evolution and molecular epidemiology of DENV have demonstrated the occurrence of genotype clusters within each serotype [39]. For this reason, genetic characterization of DENV has become a critical issue for understanding epidemic patterns of viral spread. The increase in virus transmission over the last 50 years has possibly increased its adaptive potential, resulting in more virulent genotypes which could be associated with DHF/DSS [10, 11].

In Colombia, the four serotypes of DENV have been involved in epidemics, although DENV-1 and DENV-2 have had the higher circulation rate since 1971. Moreover, since the time when the first case of DHF was described, at the end of 1989, these two serotypes have been particularly associated with severe disease. DENV-4 was first detected in 1984 and since then has been sporadically isolated from mild cases of DF.

On the other hand, DENV-3 was detected in Colombia for a short time in 1975 and was then thought to have disappeared from the country [12]. Nevertheless, DENV-3 re-appeared in Latin America in 1994 in Panama [13], and over the next six years rapidly spread to Central, South America and Caribbean countries, causing outbreaks of DF, particularly in Nicaragua, Mexico, Ecuador and Venezuela http://www.paho.org/english/hcp/hct/vbd/dengue_timeline.xls. DENV-3 was first reported in Venezuela in 1999, and was subsequently detected in Peru and Ecuador in 2000 and Brazil in 2001. In Colombia, 24 years after it had disappeared, DENV-3 was again detected in the state of Santander in 2001 [14], and officially reported by National Health Institute (Instituto Nacional de Salud, INS, Bogotá, Colombia) in early 2002 in state of La Guajira. It then dispersed all over the country, especially in those areas where dengue is endemic. Between 2003 and 2005, DENV-3 was the most frequent serotype reported by the INS. By the year 2006, co-circulation of DENV-1, DENV-2 and DENV-3 was increasingly being detected, particularly in endemic areas (Mendez JA, unpublished data).

In order to determine the arrival and dispersal patterns of DENV-3 in Colombia, a molecular phylogenetic analysis was done using the 3' region of the envelope (E) gene from 32 isolates, showing circulation of genotype III, in agreement with previous reports from neighbouring countries [10, 1517]. Additionally, the data shown here support the detection of genotype I, coincident with genotype III. These findings are in accordance with the spatial and temporal co-circulation of distinct genotypes, which could have important implications for the epidemiology of the disease.

Results and Discussion

Phylogenetic reconstruction of DENV-3

As shown in the phylogenetic tree (Figure 1), in this study DENV-3 circulation in Colombia was detected since the beginning of 2002. The results were consistent between distance and character-based methods, with minimal differences in topologies (Figure 1, Additional file 1, and data not shown). The most important findings are the detection of genotype I (or Southeast Asia/South Pacific genotype) in Colombia and its co-circulation with genotype III (or Indian genotype) [6, 18] in three states from Colombia, La Guajira, Guaviare and Huila (Figure 2). Genetic diversity within 3'end of the E gene of DENV-3 throughout the world allowed resolution of previous clustering in four lineages (genotypes) [6], and the presence of a basal clade in genotype I, would be consistent with a fifth genotype [19].
https://static-content.springer.com/image/art%3A10.1186%2F1743-422X-5-101/MediaObjects/12985_2008_Article_450_Fig1_HTML.jpg
Figure 1

Neighbor-joining phylogenetic tree of DENV-3 using a 224 bp fragment of the E gene. This figure is showing the presence of two different lineages of DENV-3 in Colombia. The Tamura-Nei nucleotide substitution model was used to estimate distance matrix. Sequences obtained in present study marked with circles and boxes correspond to genotype I and III, respectively. Bootstrap values major of 50% were maintained in the tree supporting clustering in genotypes. Horizontal branch lengths are drawn to scale.

https://static-content.springer.com/image/art%3A10.1186%2F1743-422X-5-101/MediaObjects/12985_2008_Article_450_Fig2_HTML.jpg
Figure 2

Distribution of DENV-3 genotypes I and III in Colombia. Light gray represents the presence of genotypes I, horizontal lines represent the presence of genotype III, dark gray represents the co-circulation of the genotypes I and III; and crossed lines represent DENV-3 occurrence without genotype determination in the present study. The co-circulation of both genotypes is registered in three states of Colombia (La Guajira, Guaviare and Huila).

Genetic diversity within DENV-3

Diversity within DENV-3 has been previously identified and classified [20], but they have found that genetic distance between genotypic groups is low when compared to genetic diversity in DENV-1 and -2, showing that the fixation rate is also lower [18]. By contrast, it has been published that DENV-3 has the higher substitution rate between the dengue viruses (about 7,48 substitutions/site/year) [21]. Our results shows that overall mean distance for DENV-3 as estimated for 84 sequences of 224 bp, with MEGA software is 0,070; for 104 DENV-1 sequences is 0,065 and for 60 DENV-4 sequences is 0,053. Overall mean distance for DENV-2 has not been determined in this study.

Molecular epidemiology of DENV-3 in Colombia

In the Americas, DENV-3 circulation was reported in the 1960's and 1970's, and all sequenced strains were clustered within genotype IV or American genotype [6, 18]. After these isolations, genotype IV has not been identified in any country and could be considered as an extinct genotype. In Colombia, circulation of DENV-3 was reported from 1975 – 1977 [12]. The identification was made by viral isolation in mosquito cells (C6/36) and indirect immunofluorescence, but molecular detection was not carried out. Therefore, sequences of isolated strains during this period have not been determined. It is highly probable that Colombian isolates from this period would cluster within genotype IV, like Puerto Rico strains isolated in the same year [GenBank: L11434].

In the present study, we attempted to amplify historical Colombian strains of DENV-3 isolated in 1977, but it could not be achieved, maybe due to poor samples, or improper maintenance or storage during this time. The recovery of these samples could enrich the basal clade of genotype IV, or might help in explaining the presence of an Asian genotype (genotype I) in Colombia at present if it had been circulating in the past, a very difficult hypothesis to corroborate.

The genomic region used to analyze the relation between strains has been evaluated and determined to be an informative region for genotyping [22]. Nevertheless, the complete E gene of some strains has been sequenced, and the topology results are newly confirmed (Additional file 1).

Since DENV-3 genotype III has been present in northeastern and southwestern Colombia since early 2002, different routes of introduction are possible. First, The Venezuelan origin is supported by high similarity of sequences and circulation of this genotype in Venezuela in August of 2001, when the largest epidemic caused by DENV there since the 1989 DENV-2 epidemic ended [17]. The Venezuelan origin of Colombian strains is also supported by the first isolation in La Guajira, along the frontier with Venezuela. Second, it is possible that DENV-3 genotype III had come across the frontier with Peru and/or Ecuador. The high similarity between a strain from Ecuador (DQ177898_Ecuador00) and a strain from Putumayo, Colombia (352_Putu02), a state along the border, offers hard support for this idea. Finally, the entry of genotype III into the Americas was first reported in Panama and Nicaragua in 1994 [13], so another possibility is its introduction into Colombia through the northwestern border with Panama. However, results do not support this hypothesis, not only due to the genetic distance between strains of Colombia and Panama but also mainly due to distribution of strains on northeast and southwest of Colombia. Surely not only one introduction event had occurred, but probably at least two events, via northeast and southwest of Colombia.

DENV-3 genotype I was recently described in the Americas from nine cases in Brazil, as a result of phylogenetic analysis using two fragments corresponding to C-prM and partially the E gene [23]. Here, we report the presence of this lineage in Colombia from a different region of the E gene, without recent closely-related sequences available on GenBank to date. Moreover, the related sequences corresponding to Asian strains were isolated in 1973 in Japan as an imported case and in 1980 in Guangxi, China (GenBank: AB111085 and AF317645). Samples that clustered in this lineage are located in a basal branch into genotype I, with high bootstrap support (86%) and mean distance between clades of 5%, estimated with Tamura-Nei model to be classified as a fifth different genotype, referred to as genotype V in [19]. Variability within genotype I has been demonstrated as the presence of into-clade nucleotide substitutions and branching in few years (Figure 1).

The presence of DENV-3 genotype I only in Colombia, and its close relation with Asiatic strains from 1973 and 1980, suggests that strains circulating in Colombia during the 1970's would have not been of genotype IV, like other American strains from that period, but, perhaps a strain of Asiatic origin that had been circulating without detection for over 25 years until 2002. This speculation needs more data to support it, because there is no evidence for genotype circulation in Colombia in the past, and explaining possible silent circulation without causing outbreaks for more than twenty years could be a challenge.

The presence of the Southeast Asia/South Pacific genotype has recently been detected not only in Colombia, but also in Brazil [23].

DENV-3 genotype IV was last reported in Puerto Rico in 1977 (as corroborated by sequencing) [24], but to date Colombian isolates from the same year have not been sequenced because of lack of good samples from these years. Reintroduction of other genotypes clearly has not signified displacement of genotype IV, probably because it was not present for more than twenty years, so co-circulation was not possible.

Intra-serotype recombination has been detected in natural populations of DENV [22, 2529]. Nonetheless, the significance of recombination events for increasing genetic diversity is unknown. The topology of the phylogenetic tree could be affected by recombination between strains, and then the results could be misinterpreted. Our findings obtained by using a short fragment could be a product of recombination. For this reason, we achieved sequencing of complete E gene of strains corresponding to both DENV-3 Colombian genotypes. The results of the phylogenetic reconstruction (Additional file 1) were consistent with the presence of genotypes III and I (genotype V according to [19]). Additionally, a recombination analysis using the complete E gene was carried out, but recombination events were not detected (data not shown).

As known, the potential for causing severe disease has been described for all four serotypes of DENV, and the main factors considered to explain its pathogenicity are host genetic susceptibility, antibody dependent enhancement and differences in virulence among strains [30]. It is evident that phenotype is not segregating with phylogeny, but is an evolutionary convergence, resulting from interaction of the viruses with hosts and moulded by selection to enhance its transmission and persistence [31].

Determinants of virulence have been located in three genomic regions [32] and have been tested in vitro [33], so the genotypes have been more or less related with potential to cause DHF. Recent studies have concluded that the spread of genotype III of DENV-3 from the Indian subcontinent to Africa and then to Latin America was correlated with an increase in severe cases of dengue disease [10, 34]. The ability of all serotypes to cause severe disease is an indicator of adaptive selection of this character during independent evolution of DENV serotypes. However, more efforts should be made to understand the role of viral genetics in human pathogenesis.

Although the origin of genotype I is uncertain, the co-circulation with genotype III could have epidemiologic implications if it has intra-serotype antigenic variation related with differential generation of protective antibodies and immune response [6]. It is important to take into account the low sample size, because the possibility of a more wide distribution of the genotypes I and III into the country (Figure 2).

The relevance of these results is the detection of two different genotypes in the same country, one of them of Asiatic origin, only recently described in the Americas [23]. The results underscore the need for a global strategy of genotypes circulation surveillance, because disease dynamic is more than a regional problem, involving neighbouring countries as well. The establishment of a Pan-American program would provide very useful epidemiological information about the potential of strains for causing outbreaks.

Methods

Clinical samples

The strains included in the study, with locality, year and GenBank accession numbers, are listed in table 1. Samples were collected by local hospitals in Medellín (Colombia) and Public Health Laboratories of the National Network all around the country and remitted to the National Institute of Health (Colombia) for diagnostic and epidemiological surveillance. Serum or plasma was obtained and kept at -70°C until processing. The samples cover a period of four years since reintroduction and detection of DENV-3 in Colombia (2002 – 2005).
Table 1

Colombian strains of DENV-3 sequenced in the present study.

Strain*

Name

Location

Date

Genbank accession #

Genotype (Subtype)

388280

375_SAnd03

San Andrés

11/09/2003

EU003494

SE Asia/S.Pacific (I)

388887

389_Guaj03

Guajira

14/11/2003

EU003495

SE Asia/S.Pacific (I)

389520

395_NSan04

Norte de Santander

20/01/2004

EU003496

SE Asia/S.Pacific (I)

390192

400_Guaj04

Guajira

09/02/2004

EU003497

SE Asia/S.Pacific (I)

391300

417_Guav04

Guaviare

15/07/2004

EU003498

SE Asia/S.Pacific (I)

391933

429_Huil04

Huila

15/10/2004

EU003499

SE Asia/S.Pacific (I)

V-599

591VI

-

-

EU003511

SE Asia/S.Pacific (I)

-

DV06_Ant05

Antioquia

22/06/2005

EU003514

SE Asia/S.Pacific (I)

-

DV20_Ant05

Antioquia

21/11/2005

EU003513

SE Asia/S.Pacific (I)

384119

520_Guaj02

Guajira

22/01/2002

EU003509

India (III)

384584

221_Guaj02

Guajira

27/03/2002

EU003483

India (III)

384826

484_Putu02

Putumayo

11/04/2002

EU003504

India (III)

385233

352_Putu02

Putumayo

04/06/2002

EU003487

India (III)

386891

517_Caqu03

Caquetá

14/03/2003

EU003507

India (III)

386990

358_Sant03

Santander

01/04/2003

EU003488

India (III)

387023

359_Caqu03

Caquetá

04/04/2003

EU003489

India (III)

387124

363_Caqu03

Caquetá

14/04/2003

EU003490

India (III)

387129

366_Caqu03

Caquetá

14/04/2003

EU003491

India (III)

387130

367_Caqu03

Caquetá

14/04/2003

EU003492

India (III)

387131

368_Caqu03

Caquetá

14/04/2003

EU003493

India (III)

387173

464_2003

-

24/04/2003

EU003503

India (III)

388446

233_Guaj03

Guajira

22/09/2003

EU003484

India (III)

391713

518_Putu04

Putumayo

22/09/2004

EU003508

India (III)

391771

535_Huil04

Huila

27/09/2004

EU003512

India (III)

392438

530_Guav05

Guaviare

03/02/2005

EU003510

India (III)

393084

449_Meta05

Meta

12/05/2005

EU003500

India (III)

393198

456_Meta05

Meta

26/05/2005

EU003501

India (III)

393273

247_Guav05

Guaviare

10/06/2005

EU003485

India (III)

393282

249_Meta05

Meta

10/06/2005

EU003486

India (III)

393492

461Guav05

Guaviare

07/07/2005

EU003502

India (III)

469-1

492VI

-

-

EU003505

India (III)

470-12

493VI

-

-

EU003506

India (III)

*Code in Laboratorio de Virologia, INS repository (Instituto Nacional de Salud, Bogotá, Colombia).

Virus isolation

C6/36 cells cultured in Dulbecco's modified Eagle's medium (DMEM), were infected with 0.15 ml of samples and incubated for 10 days at 28°C, washed with PBS, removed by hitting the culture tubes manually and seeded on slides. Cells were then fixed with acetone and the indirect immunofluorescence procedure was carried out incubating the cells with serotype-specific monoclonal antibodies (kindly donated by Dr. Elizabeth Hunsperger, CDC Puerto Rico) for 60 minutes and then washed with PBS and incubated for another 60 minutes with a commercial secondary antibody conjugated with fluorescein isotyocianate.

RNA extraction

Aliquots of 140 μl of serum or supernatants of cell cultures were placed into 540 μl of AVL buffer with Carrier RNA and used to extract the viral RNA with QIAamp Viral RNA Minikit (QIAGEN, Germany) as indicated by manufacturer. RNA obtained in 60 μl of AVE buffer was stored at -70°C and used in the RT-PCR. Alternatively, the total RNA of some samples was extracted by the use of TRIZOL® LS (INVITROGEN, Inc., USA), and a final volume of 15 μl was recovered in these cases.

RT-PCR and nested-PCR

The RT-PCR and nested-PCR have been previously described [35]. When viral load was too low, nested-PCR was used to detect DENV directly on clinical samples, so sensitivity of detection was increased more than five logarithms and passage of viruses in cell cultures was avoided (data not shown). RT-PCR primers were designated to amplify an intergenic region E/NS1 of 776 bp, and nested-PCR to amplify an internal region of 350 bp.

DNA sequencing

Products of RT-PCR or nested-PCR were purified using QIAquick PCR Purification Kit (QIAGEN, Germany). Sequencing reactions on both strands were performed with 10 pmol of the primers used for the second round of amplification, and the ABI Prism Dye Terminator Cycle Sequencing Ready Reaction Kit (APPLIED BIOSYSTEMS, USA), and analysed using an ABI model 377 automated sequencer (APPLIED BIOSYSTEMS, USA).

Sequence editing

Four sequences were obtained for each sample, two sequences with sense and two with antisense primer. Editing and consensus obtaining were performed with the SeqMan module of Lasergene (DNASTAR Inc. Software, Madison, Wis.).

Sequences on GenBank corresponding to different lineages of DENV-3 were downloaded and aligned with the consensus sequences obtained in this study, using Clustal W software [36]. Additionally, a visual correction of alignment was done. A fragment of 224 bp was used for phylogenetic reconstructions corresponding to the 3' end of the E gene (nucleotides 1256 to 1479). The portion of the NS1 gene amplified with the nested-PCR was excluded from the analysis due to the absence of this portion in the majority of reported sequences.

Phylogenetic analysis

Alignment of the sequences obtained in the present study (n = 32) (Table 1) and homologous sequences for DENV-3 available on GenBank (n = 68) (Table 2) were used for phylogenetic reconstructions. Many sequences of different strains were completely identical to the fragment analysed, and so one sequence was used for analysis, corresponding to the first isolation.
Table 2

List of isolates used in the present study with GenBank accession number, year and location.

GenBank Accesión #

Label

Genotypea

Year

Location

AB189125

Indones98a

I

1998

Indonesia

AY858037

Indones04a

I

2004

Indonesia

AY858043

Indones04b

I

2004

Indonesia

AY858039

Indones98b

I

1998

Indonesia

AY912455

Indones98c

I

1998

Indonesia

AY912454

Indones98d

I

1998

Indonesia

L11428

Indones85

I

1985

Indonesia

AY858038

Indones88

I

1988

Indonesia

L11429

Malaysia74

I

1974

Malaysia

L11425

Indones73

I

1973

Indonesia

AB189128

Indones98e

I

1998

Indonesia

DQ401695

Philippi97

I

1997

Philippines

AB219139

Indones05a

I

2005

Indonesia

AB219138

Indones05b

I

2005

Indonesia

AY744680

Tahiti90

I

1990

Tahiti

L11427

Malaysia81

I

1981

Malaysia

L11619

Tahiti89a

I

1989

Tahiti

AY744678

Tahiti89b

I

1989

Tahiti

DQ401690

Indones82

I

1982

Indonesia

AY744684

Tahiti92

I

1992

Tahiti

L11432

Philippi83

I

1983

Philippines

AF317645

China80

I (V)b

1980

China

M93130

Philippi56

I (V)b

1956

Philippines

AB111085

JaponImp73

I (V)b

1973

Japan

AF147457

Malaysia92

II

1992

Malaysia

AY676370

Thailand81

II

1981

Thailand

AY676368

Thailand85

II

1985

Thailand

AY676359

Thailand80

II

1980

Thailand

AF533079

Thailan87a

II

1987

Thailand

AY135419

Thailan87b

II

1987

Thailand

AY145715

Thailand89

II

1989

Thailand

AY145716

Thailand91

II

1991

Thailand

AY338493

Malaysia94

II

1994

Malaysia

AY145730

Thailand97

II

1997

Thailand

AY145726

Thailand96

II

1996

Thailand

AY145718

Thailand92

II

1992

Thailand

AY145723

Thailand94

II

1994

Thailand

AY496872

Banglade01

II

2001

Bangladesh

AB111080

Banglade00

II

2000

Bangladesh

L11424

India84

III

1984

India

AY099336

SriLanka00

III

2000

SriLanka

AY099337

Martiniq99

III

1999

Martinique

AB111081

Cambodia00

III

2000

Cambodia

AY702032

116_Cuba00

III

2000

Cuba

AY038605

Brazil00

III

2000

Brazil

AY146772

Venezue01a

III

2001

Venezuela

AY146765

Venezue00a

III

2000

Venezuela

AY146767

Venezue00b

III

2000

Venezuela

AY146776

Venezue01b

III

2001

Venezuela

AY702030

580_Cuba01

III

2001

Cuba

AY702033

Nicaragu94

III

1994

Nicaragua

DQ341209

Panama94

III

1994

Panama

DQ341208

Somalia93

III

1993

Somalia

DQ341202

Mexico95

III

1995

Mexico

DQ371245

Venezue01c

III

2001

Venezuela

DQ177899

Ecuador00a

III

2000

Ecuador

DQ177900

Peru01

III

2001

Peru

DQ367720

Venezue01d

III

2001

Venezuela

DQ177898

Ecuador00b

III

2000

Ecuador

DQ177902

Peru05a

III

2005

Peru

DQ177897

Peru05b

III

2005

Peru

DQ177887

Bolivia03

III

2003

Bolivia

AY960630

GOI1099

III

-

Brazil

L11434

PRico77a

IV

1977

Puerto Rico

L11439

Tahiti65

IV

1965

Tahiti

AY146762

PRico63a

IV

1963

Puerto Rico

L11433

PRico63b

IV

1963

Puerto Rico

AY146761

PRico77b

IV

1977

Puerto Rico

a Genotypes as reported by Lanciotti et al. (1994).

b Genotype V as reported by Wittke et al. (2002).

The strain 359_Caqu03 was completely identical to 363_Caqu03, 366_Caqu03, 367_Caqu03, 368_Caqu03, and 464_2003; strain 449Meta05 was identical to 456_Guav05 and 461Guav05; strain 352_ Putu02 to 484_Putu02; strain 221_Guaj02 to 233_Guaj03, 517_Caqu03, 518_putu04, 247_Guav05 and 530_Guav05; and finally, strain 375_SAnd03 was identical to 389_Guaj03, 395_NSan04, 417_Guav04, 429_Huil04, 535_Huil04 and DV06_Ant05.

The phylogenetic trees were estimated for the 224 bp fragment, corresponding to the 3' end of the E gene. Initially, the neighbour-joining algorithm was used with 10000 bootstrap replicates and the Tamura-Nei model of nucleotide substitution with MEGA 3.1 software [37]. Maximum parsimony and Maximum Likelihood trees were obtained with PAUP* [38]. For selecting the model of substitution, MODELTEST software and current dataset were used and the resulting parameters were used for running maximum likelihood analysis. Trees were rooted using genotype IV, only for graphical purposes.

Conclusion

The more important finding of this work is the co-circulation of genotype III of DENV-3, widely distributed, and the recently reported genotype I, never before described in the Americas, in three Colombian states. Co-circulation of different genotypes in an area could be related with the current association between DENV-3 infection and severity of disease. Moreover, intra-serotype antigenic variation related with differential generation of protective antibodies and immune response could be one of the reasons for the high epidemiological impact of DENV-3 in the Americas.

Notes

Declarations

Acknowledgements

We thank the Red Nacional de Laboratorios – Instituto Nacional de Salud, and personnel of the laboratory in Hospitals Rosalpi (Bello) and Zamora (Medellín) for helping in the collection of some clinical samples. We are grateful to Pablo Martínez and Noelia Reyes for technical assistance in amplifying and sequencing in the ISCIII; Sair Arboleda at the Laboratorio de Chagas for her assistance in designing of the distribution map; and Dr. Edward Holmes for his assistance in the recombination analysis. RIVE-CYTED (Red Iberoamericana de Virosis Emergentes) allowed the authors to meet with several other researchers in the field. Jon Riddle contributed with his excellent English language skills.

This research was supported by Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología Francisco José de Caldas – COLCIENCIAS grant 11150416336 CT 234–2004 from the Colombian government and CODI E00943 from the Universidad de Antioquia.

Authors’ Affiliations

(1)
Viral Biology – PECET, Sede de Investigación Universitaria, Universidad de Antioquia
(2)
Grupo de Inmunovirología, Sede de Investigación Universitaria, Universidad de Antioquia
(3)
Laboratorio de Virología, Instituto Nacional de Salud
(4)
Laboratorio de Arbovirus y Enfermedades Víricas Importadas, Centro Nacional de Microbiología, Instituto de Salud Carlos III

References

  1. Lindenbach BD, Thiel HJ, Rice CM: Flaviviridae: The Viruses and Their Replication. In Fields Virology. Volume 1. 5th edition. Edited by: Knipe DM, Howley PM. Philadelphia, USA , Lippincott Williams & Wilkins, a Wolters Kluwer Business; 2007:1101-1152.Google Scholar
  2. Gubler DJ, Clark GG: Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis 1995,1(2):55-57.PubMed CentralView ArticlePubMedGoogle Scholar
  3. Chungue E, Cassar O, Drouet MT, Guzman MG, Laille M, Rosen L, Deubel V: Molecular epidemiology of dengue-1 and dengue-4 viruses. J Gen Virol 1995, 76 ( Pt 7): 1877-1884.View ArticleGoogle Scholar
  4. Goncalvez AP, Escalante AA, Pujol FH, Ludert JE, Tovar D, Salas RA, Liprandi F: Diversity and evolution of the envelope gene of dengue virus type 1. Virology 2002,303(1):110-119.View ArticlePubMedGoogle Scholar
  5. Lanciotti RS, Gubler DJ, Trent DW: Molecular evolution and phylogeny of dengue-4 viruses. J Gen Virol 1997, 78 ( Pt 9): 2279-2284.View ArticlePubMedGoogle Scholar
  6. Lanciotti RS, Lewis JG, Gubler DJ, Trent DW: Molecular evolution and epidemiology of dengue-3 viruses. J Gen Virol 1994, 75 ( Pt 1): 65-75.View ArticleGoogle Scholar
  7. Lewis JA, Chang GJ, Lanciotti RS, Kinney RM, Mayer LW, Trent DW: Phylogenetic relationships of dengue-2 viruses. Virology 1993,197(1):216-224.View ArticlePubMedGoogle Scholar
  8. Rico-Hesse R: Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Virology 1990,174(2):479-493.View ArticlePubMedGoogle Scholar
  9. Twiddy SS, Farrar JJ, Vinh Chau N, Wills B, Gould EA, Gritsun T, Lloyd G, Holmes EC: Phylogenetic relationships and differential selection pressures among genotypes of dengue-2 virus. Virology 2002,298(1):63-72.View ArticlePubMedGoogle Scholar
  10. Messer WB, Gubler DJ, Harris E, Sivananthan K, de Silva AM: Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis 2003,9(7):800-809.PubMed CentralView ArticlePubMedGoogle Scholar
  11. Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, Ramos C, Boshell J, de Mesa MT, Nogueira RM, da Rosa AT: Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 1997,230(2):244-251.View ArticlePubMedGoogle Scholar
  12. Boshell J, Groot H, Gacharna MG, Marquez G, Gonzalez M, Gaitan MO, Berlie C, Martinez M: Dengue en Colombia. Biomédica 1986,6(1 y 2):101-106.View ArticleGoogle Scholar
  13. CDC: Dengue type 3 infection. Nicaragua and Panama, October-November 1994. Wkly Epidemiol Rec 1995, 70: 41-43.Google Scholar
  14. Ocazionez RE, Cortes FM, Villar LA, Gomez SY: Temporal distribution of dengue virus serotypes in Colombian endemic area and dengue incidence. Re-introduction of dengue-3 associated to mild febrile illness and primary infection. Mem Inst Oswaldo Cruz 2006,101(7):725-731.View ArticlePubMedGoogle Scholar
  15. Mamani E, Garcia M, Gutierrez V, Cabezas C, Harris E: Tipificación molecular del virus dengue 3 durante el brote epidémico de dengue clásico en Lima, Perú, 2005. Rev Peru Med Exp Salud Publica 2005.,22(3):
  16. Nogueira RM, Schatzmayr HG, de Filippis AM, dos Santos FB, da Cunha RV, Coelho JO, de Souza LJ, Guimaraes FR, de Araujo ES, De Simone TS, Baran M, Teixeira G Jr., Miagostovich MP: Dengue virus type 3, Brazil, 2002. Emerg Infect Dis 2005,11(9):1376-1381.PubMed CentralView ArticlePubMedGoogle Scholar
  17. Uzcategui NY, Comach G, Camacho D, Salcedo M, Cabello de Quintana M, Jimenez M, Sierra G, Cuello de Uzcategui R, James WS, Turner S, Holmes EC, Gould EA: Molecular epidemiology of dengue virus type 3 in Venezuela. J Gen Virol 2003,84(Pt 6):1569-1575.View ArticlePubMedGoogle Scholar
  18. Rico-Hesse R: Microevolution and virulence of dengue viruses. Adv Virus Res 2003, 59: 315-341.PubMed CentralView ArticlePubMedGoogle Scholar
  19. Wittke V, Robb TE, Thu HM, Nisalak A, Nimmannitya S, Kalayanrooj S, Vaughn DW, Endy TP, Holmes EC, Aaskov JG: Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period. Virology 2002,301(1):148-156.View ArticlePubMedGoogle Scholar
  20. Trent DW, Manske CL, Fox GE, Chu MC, Kliks S, Monath TP: The molecular epidemiology of dengue viruses: Genetic variation and microevolution. Appl Virol Res 1990, 2: 293-315.Google Scholar
  21. Twiddy SS, Holmes EC, Rambaut A: Inferring the rate and time-scale of dengue virus evolution. Mol Biol Evol 2003,20(1):122-129.View ArticlePubMedGoogle Scholar
  22. Domingo C, Palacios G, Jabado O, Reyes N, Niedrig M, Gascon J, Cabrerizo M, Lipkin WI, Tenorio A: Use of a short fragment of the C-terminal E gene for detection and characterization of two new lineages of dengue virus 1 in India. J Clin Microbiol 2006,44(4):1519-1529.PubMed CentralView ArticlePubMedGoogle Scholar
  23. Barcelos Figueiredo L, Batista Cecilio A, Portela Ferreira G, Paiva Drumond B, Germano de Oliveira J, Bonjardim CA, Peregrino Ferreira PC, Geessien Kroon E: Dengue virus 3 genotype 1 associated with dengue Fever and dengue hemorrhagic Fever, Brazil. Emerg Infect Dis 2008,14(2):314-316.View ArticlePubMedGoogle Scholar
  24. Morens DM, Rigau-Perez JG, Lopez-Correa RH, Moore CG, Ruiz-Tiben EE, Sather GE, Chiriboga J, Eliason DA, Casta-Velez A, Woodall JP: Dengue in Puerto Rico, 1977: public health response to characterize and control an epidemic of multiple serotypes. Am J Trop Med Hyg 1986,35(1):197-211.PubMedGoogle Scholar
  25. AbuBakar S, Wong PF, Chan YF: Emergence of dengue virus type 4 genotype IIA in Malaysia. J Gen Virol 2002,83(Pt 10):2437-2442.View ArticlePubMedGoogle Scholar
  26. Holmes EC, Worobey M, Rambaut A: Phylogenetic evidence for recombination in dengue virus. Mol Biol Evol 1999,16(3):405-409.View ArticlePubMedGoogle Scholar
  27. Twiddy SS, Holmes EC: The extent of homologous recombination in members of the genus Flavivirus. J Gen Virol 2003,84(Pt 2):429-440.View ArticlePubMedGoogle Scholar
  28. Uzcategui NY, Camacho D, Comach G, Cuello de Uzcategui R, Holmes EC, Gould EA: Molecular epidemiology of dengue type 2 virus in Venezuela: evidence for in situ virus evolution and recombination. J Gen Virol 2001,82(Pt 12):2945-2953.View ArticlePubMedGoogle Scholar
  29. Worobey M, Rambaut A, Holmes EC: Widespread intra-serotype recombination in natural populations of dengue virus. Proc Natl Acad Sci U S A 1999,96(13):7352-7357.PubMed CentralView ArticlePubMedGoogle Scholar
  30. Holmes EC, Burch SS: The causes and consequences of genetic variation in dengue virus. Trends Microbiol 2000,8(2):74-77.View ArticlePubMedGoogle Scholar
  31. Ferguson N, Anderson R, Gupta S: The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens. Proc Natl Acad Sci U S A 1999,96(2):790-794.PubMed CentralView ArticlePubMedGoogle Scholar
  32. Leitmeyer KC, Vaughn DW, Watts DM, Salas R, Villalobos I, Ramos C, Rico-Hesse R: Dengue virus structural differences that correlate with pathogenesis. J Virol 1999,73(6):4738-4747.PubMed CentralPubMedGoogle Scholar
  33. Cologna R, Rico-Hesse R: American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol 2003,77(7):3929-3938.PubMed CentralView ArticlePubMedGoogle Scholar
  34. Guzman MG, Vazquez S, Martinez E, Alvarez M, Rodriguez R, Kouri G, de los Reyes J, Acevedo F: [Dengue in Nicaragua, 1994: reintroduction of serotype 3 in the Americas]. Bol Oficina Sanit Panam 1996,121(2):102-110.PubMedGoogle Scholar
  35. Domingo C, Palacios G, Niedrig M, Cabrerizo M, Jabado O, Reyes N, Lipkin WI, Tenorio A: A New Tool for the Diagnosis and Molecular Surveillance of Dengue Infections in Clinical Samples. Dengue Bulletin 2004, 28: 87 -895.Google Scholar
  36. Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22: 4673-4680.PubMed CentralView ArticlePubMedGoogle Scholar
  37. Kumar S, Tamura K, Nei M: MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 2004,5(2):150-163.View ArticlePubMedGoogle Scholar
  38. Swofford DL: PAUP*. Phylogenetic Analysis Using Parsimony (*and Other Methods). Version 4 edition. Sunderland, Massachusetts , Sinauer Associates; 2002.Google Scholar

Copyright

© Usme-Ciro et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.